The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

The change removes several major safety notices from common hormone products, but doctors say decisions should remain individualized.

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

A federal judge ruled Georgia’s hormone therapy ban unconstitutional and ordered continued care for transgender inmates.

An FDA panel pushes reclassify testosterone therapy by recommending removal of controlled substance status and expanding treatment eligibility.

The Georgia case was brought on behalf of transgender inmates by the Center for Constitutional Rights after Georgia enacted a ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

As of last month, according to the US Department of Health and Human Services, the FDA is requesting that companies remove ...

Two decades after the Women’s Health Initiative study, evolving research on menopause hormone therapy is shedding new light ...

Allison Aubrey is a Washington-based correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She has reported extensively on the coronavirus pandemic ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

Results from the WHI study instilled "mass fear" and not facts, in women. May 22, 2012— -- A reappraisal of the NIH Women's Health Initiative study has found that "the age when women start ...